Literature DB >> 26337835

Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.

Nadir Kheir1, Ahmed Awaisu2, Hoda Gad3, Shereen Elazzazy4, Farah Jibril4, Mawadda Gajam4.   

Abstract

BACKGROUND: The application of clinical pharmacokinetics (PK) is essential when providing pharmaceutical care. Appropriate application of PK monitoring results in improved patient outcomes including decreased mortality, length of treatment, length of hospital stay, and adverse effects of drug therapy. Despite the well-documented evidence of benefits of clinical PK services, many pharmacists find it challenging to apply PK in clinical practice.
OBJECTIVE: To evaluate pharmacists' training backgrounds, attitude, practices, and perceived barriers pertaining to the application of PK in clinical practice in Qatar.
SETTING: All hospitals under Hamad Medical Corporation, the main healthcare provider in Qatar.
METHODOLOGY: This was a cross-sectional, descriptive study that was conducted between October 2012 and January 2013, using a self-administered web-based survey. Pharmacists were eligible to participate if they: (1) were working as full-time hospital pharmacists and; (2) have been in practice for at least 1 year. MAIN OUTCOME MEASURES: PK contents learned in undergraduate curriculum; perception towards the PK contents and instructions received in the undergraduate curriculum and; application of PK in current clinical practice.
RESULTS: A total of 112 pharmacists responded to the questionnaire. The majority of the respondents (n = 91; 81.3 %) reported that they had received PK course(s) in their undergraduate curriculum. Similarly, the majority (70-80 %) of them agreed that the undergraduate PK courses or contents they received were important and relevant to their current practice. The pharmacists identified spending more time on dispensing and inventory issues rather than clinical practice, scarce resources, and manual rather than computerized PK calculations as some of the barriers they encountered in learning about PK and its application. The characteristics of the surveyed pharmacists such as gender, age, highest academic degree, and country of graduation did not influence the pharmacists' perception and attitudes towards PK teaching and application (p > 0.05).
CONCLUSION: PK course contents were perceived to lack depth and relevance to practice, and pharmacist had no experiential training that included aspects of PK. These, and other issues, result in poor application of PK in practice.

Entities:  

Keywords:  Clinical pharmacists; Clinical practice; Perceived barriers; Pharmacokinetics; Qatar

Mesh:

Year:  2015        PMID: 26337835     DOI: 10.1007/s11096-015-0183-3

Source DB:  PubMed          Journal:  Int J Clin Pharm


  20 in total

1.  The design and assessment of questionnaires in clinical research.

Authors:  S M Saw; T P Ng
Journal:  Singapore Med J       Date:  2001-03       Impact factor: 1.858

Review 2.  Cost-effectiveness of therapeutic drug monitoring: a systematic review.

Authors:  D J Touw; C Neef; A H Thomson; A A Vinks
Journal:  Ther Drug Monit       Date:  2005-02       Impact factor: 3.681

3.  Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs.

Authors:  Chaveewan Ratanajamit; Peerasak Kaewpibal; Suwanna Setthawacharavanich; Damrongsak Faroongsarng
Journal:  J Med Assoc Thai       Date:  2009-11

Review 4.  Pharmacokinetic monitoring of antiepileptic drugs.

Authors:  A Aldaz; R Ferriols; D Aumente; M V Calvo; M R Farre; B García; R Marqués; P Mas; B Porta; M Outeda; D Soy
Journal:  Farm Hosp       Date:  2011-05-13

5.  Unskilled and unaware of it: how difficulties in recognizing one's own incompetence lead to inflated self-assessments.

Authors:  J Kruger; D Dunning
Journal:  J Pers Soc Psychol       Date:  1999-12

6.  Effect of theophylline pharmacokinetic monitoring service on cost and quality of care.

Authors:  C R Lehmann; R G Leonard
Journal:  Am J Hosp Pharm       Date:  1982-10

7.  Reduction of digoxin toxicity associated with measurement of serum levels. A report from the Boston Collaborative Drug Surveillance Program.

Authors:  D W Duhme; D J Greenblatt; J Koch-Weser
Journal:  Ann Intern Med       Date:  1974-04       Impact factor: 25.391

8.  Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients.

Authors:  Jeffrey J Cies; Laurie Varlotta
Journal:  Pediatr Pulmonol       Date:  2012-12-31

9.  Evaluation of a digoxin pharmacokinetic monitoring service in a community hospital.

Authors:  J R Horn; D B Christensen; P A deBlaquiere
Journal:  Drug Intell Clin Pharm       Date:  1985-01

10.  Physicians' perceptions, expectations, and experience with pharmacists at Hamad Medical Corporation in Qatar.

Authors:  Manal Zaidan; Rajvir Singh; Mayyada Wazaify; Linda Tahaineh
Journal:  J Multidiscip Healthc       Date:  2011-04-08
View more
  1 in total

1.  Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible.

Authors:  Kashif Hussain; Muhammad Sohail Salat; Shahzad Rauf; Manoj Rathi; Midhat Khan; Fizzah Naz; Wasif Ahmed Khan; Rahila Ikram; Gul Ambreen
Journal:  BMC Pharmacol Toxicol       Date:  2022-08-20       Impact factor: 2.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.